Pfizer’s new distribution model has sent shockwaves through the industry.
It is an audacious commercial move, and the Pfizer was not obliged to consult the Guild about its intentions.
Aware of significant problems when Pfizer made such a move in the UK some years ago, the Guild was pleased to be made aware of this market change, and to be given the opportunity to have some input.
The Guild entered a dialogue with Pfizer to do our best to protect members and ensure the best possible service delivery commitment under their direct-to-pharmacy model.
The Guild does not ‘endorse’ Pfizer’s model, nor were we asked to do so. We moved to secure a number of key tangible results for community pharmacy....
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.